crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer
Most Cited Paper
in Cancer-related molecular mechanisms research
18 Months Post-Publication
Class of 2026
“crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/cancer-related-molecular-mechanisms-research/2026/
Topics
crVDAC3 · Ferroptosis · HSPB1 · Ubiquitination · trastuzumab deruxtecan · HER2-low breast cancer · drug resistance · VDAC3 · HSPB1 · antibody-drug conjugate resistance
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Cancer-related molecular mechanisms research Papers, Class of 2026. https://pri.pepkio.com/top-papers/cancer-related-molecular-mechanisms-research/2026. Accessed 2026-07-20. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459